The Shawcross Lab is led by Professor Debbie Shawcross
Chronic liver disease is increasing on a global scale and patients are vulnerable to developing infections and death. The main aim of the lab is to characterise the immune-gut-liver-brain axis in patients and to develop interventions which normalise the abnormal gut microbiome reducing the development of complications and liver failure.
